Literature DB >> 22539258

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.

Christian G Bien1, Angela Vincent, Michael H Barnett, Albert J Becker, Ingmar Blümcke, Francesc Graus, Kurt A Jellinger, David E Reuss, Teresa Ribalta, Jürgen Schlegel, Ian Sutton, Hans Lassmann, Jan Bauer.   

Abstract

Classical paraneoplastic encephalitis syndromes with 'onconeural' antibodies directed to intracellular antigens, and the recently described paraneoplastic or non-paraneoplastic encephalitides and antibodies against both neural surface antigens (voltage-gated potassium channel-complexes, N-methyl-d-aspartate receptors) and intracellular antigens (glutamic acid decarboxylase-65), constitute an increasingly recognized group of immune-mediated brain diseases. Evidence for specific immune mechanisms, however, is scarce. Here, we report qualitative and quantitative immunopathology in brain tissue (biopsy or autopsy material) of 17 cases with encephalitis and antibodies to either intracellular (Hu, Ma2, glutamic acid decarboxylase) or surface antigenic targets (voltage-gated potassium channel-complex or N-methyl-d-aspartate receptors). We hypothesized that the encephalitides with antibodies against intracellular antigens (intracellular antigen-onconeural and intracellular antigen-glutamic acid decarboxylase groups) would show neurodegeneration mediated by T cell cytotoxicity and the encephalitides with antibodies against surface antigens would be antibody-mediated and would show less T cell involvement. We found a higher CD8/CD3 ratio and more frequent appositions of granzyme-B(+) cytotoxic T cells to neurons, with associated neuronal loss, in the intracellular antigen-onconeural group (anti-Hu and anti-Ma2 cases) compared to the patients with surface antigens (anti-N-methyl-d-aspartate receptors and anti-voltage-gated potassium channel complex cases). One of the glutamic acid decarboxylase antibody encephalitis cases (intracellular antigen-glutamic acid decarboxylase group) showed multiple appositions of GrB-positive T cells to neurons. Generally, however, the glutamic acid decarboxylase antibody cases showed less intense inflammation and also had relatively low CD8/CD3 ratios compared with the intracellular antigen-onconeural cases. Conversely, we found complement C9neo deposition on neurons associated with acute neuronal cell death in the surface antigen group only, specifically in the voltage-gated potassium channel-complex antibody patients. N-methyl-d-aspartate receptors-antibody cases showed no evidence of antibody and complement-mediated tissue injury and were distinguished from all other encephalitides by the absence of clear neuronal pathology and a low density of inflammatory cells. Although tissue samples varied in location and in the stage of disease, our findings strongly support a central role for T cell-mediated neuronal cytotoxicity in encephalitides with antibodies against intracellular antigens. In voltage-gated potassium channel-complex encephalitis, a subset of the surface antigen antibody encephalitides, an antibody- and complement-mediated immune response appears to be responsible for neuronal loss and cerebral atrophy; the apparent absence of these mechanisms in N-methyl-d-aspartate receptors antibody encephalitis is intriguing and requires further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539258     DOI: 10.1093/brain/aws082

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  180 in total

Review 1.  Neuronal surface antibody-mediated autoimmune encephalitis.

Authors:  Jenny J Linnoila; Myrna R Rosenfeld; Josep Dalmau
Journal:  Semin Neurol       Date:  2014-11-04       Impact factor: 3.420

2.  Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.

Authors:  Jesús Planagumà; Holger Haselmann; Francesco Mannara; Mar Petit-Pedrol; Benedikt Grünewald; Esther Aguilar; Luise Röpke; Elena Martín-García; Maarten J Titulaer; Pablo Jercog; Francesc Graus; Rafael Maldonado; Christian Geis; Josep Dalmau
Journal:  Ann Neurol       Date:  2016-08-02       Impact factor: 10.422

Review 3.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

4.  Identification of anti-Sez6l2 antibody in a patient with cerebellar ataxia and retinopathy.

Authors:  Hiroaki Yaguchi; Ichiro Yabe; Hidehisa Takahashi; Fumihiko Okumura; Akiko Takeuchi; Kazuhiro Horiuchi; Takahiro Kano; Atsuhiro Kanda; Wataru Saito; Masaki Matsumoto; Keiichi I Nakayama; Shigetsugu Hatakeyama; Hidenao Sasaki
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

Review 5.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

6.  Neuropathologic features of anti-dipeptidyl-peptidase-like protein-6 antibody encephalitis.

Authors:  Gorazd B Stokin; Mara Popović; Ellen Gelpi; Aleš Kogoj; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2014-12-17       Impact factor: 9.910

Review 7.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 8.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

Review 9.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 10.  [Paraneoplastic neurological syndromes].

Authors:  O Stich; S Rauer
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.